Matrine for injection
Function and Efficacy
Intraperitoneal injection of matrine into mice with cholestatic jaundice induced by 1-naphthyl isothiocyanate can reduce the levels of serum aspartate aminotransferase, alanine aminotransferase and serum conjugated bilirubin, and alleviate liver cell damage in model animals.
Ingredients
Matrine
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| MatrineIngredients |
Intraperitoneal injection of the drug into mice with cholestatic jaundice induced by 1-naphthyl isothiocyanate can reduce serum aspartate aminotransferase, alanine aminotransferase and serum conjugated bilirubin levels, and alleviate liver cell damage in the model animals. More |
519-02-8 | 8 |
Appearance
This product is white loose mass or powder, hygroscopic.
Indication
Used to restore alanine aminotransferase and bilirubin to normal in patients with chronic hepatitis.
Usage and Dosage
Dissolve 150 mg of this product in an appropriate amount of water for injection and add it to 250-500 ml of 10% glucose injection. Slowly drip intravenously once a day for two months as a course of treatment.
Adverse Reactions
Occasionally, there may be adverse reactions such as mild nausea, abdominal distension, headache, and dizziness.
Precautions
It is contraindicated for those who are allergic to this product.
Storage
Keep in a light-proof, sealed, cool place.
Packaging Specification
0.15g
Manufacturer
Hubei Qianjiang Pharmaceutical Co., Ltd.
-
Founded in:
2009-09-18 -
Address:
No. 1, Zhanghua South Road, Qianjiang City -
Tax NO.:
91429005695102248D -
Registered Funds:
300 million yuan -
Website:
-
Email: